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Periodontal ligament and gingival 
fibroblasts participate in the production 
of TGF-β, interleukin (IL)-8 and IL-10
Abstract: The aim of this study was to quantify and compare the pro-
duction of transforming growth factor beta (TGF-β), interleukin (IL)-8 
and IL-10 by human cultured periodontal ligament and gingival fibro-
blasts both obtained from the same donors challenged with lipopolysac-
charide (LPS) from Porphyromonas gingivalis. Fibroblasts were exposed 
to 0.1-10 µg/mL of LPS from P. gingivalis and after 24 h the superna-
tants were collected and analyzed by enzyme-linked immunosorbent 
assay (ELISA). TGF-β protein production was upregulated in a concen-
tration-dependent manner, mainly in gingival fibroblasts, which was sta-
tistically significant when challenged by 10 µg/mL LPS. Additionally, at 
this concentration, gingival fibroblasts had almost a two-fold increase 
in the amount of TGF-β when compared to periodontal ligament fibro-
blasts. Both periodontal ligament and gingival fibroblasts showed an in-
crease in IL-8 production when challenged with 1 µg/mL and 10 µg/mL 
LPS. IL-10 production remained unaffected when challenged by any of 
the LPS concentrations tested in either periodontal ligament or gingival 
fibroblasts. Our results demonstrate that periodontal ligament and gingi-
val fibroblasts when challenged by LPS from P. gingivalis with 24 h may 
play a critical role in producing TGF-β and IL-8 but not IL-10.
Descriptors: Periodontitis; Fibroblasts; Cytokines; Porphyromonas 
gingivalis.
Introduction
Periodontitis is a complex chronic infectious disease that leads to the 
destruction of the tooth-supporting tissues, including alveolar bone, and 
that leads to tooth loss.1 The presence of periodontopathogens, such as 
Porphyromonas gingivalis, is considered the major etiologic agent in 
periodontitis.2 P. gingivalis is a Gram-negative anaerobic bacterium that 
possesses a number of virulence factors, including lipopolysaccharides 
(LPS).3 LPS acts as a potent stimulus to a variety of host cells, which sub-
sequently results in the expression of inflammatory cytokines leading to 
the development and progression of the related host immune response in 
periodontal diseases.4
Numerous studies have demonstrated that cytokine networks play an 
important role in the initiation and progression of periodontal disease.5 
Interleukin (IL)-8 is a chemokine produced by a variety of tissues, and it 
is a potent inducer of neutrophil chemotaxis and activation.6 The stimu-
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lation of human gingival fibroblasts with highly pu-
rified P. gingivalis LPS led to mRNA expression of 
IL-8.7 In contrast, IL-10, an anti-inflammatory cyto-
kine, plays a major role in suppressing immune and 
inflammatory responses.8 Indeed, IL-10 presents a 
protective role toward tissue destruction, inhibiting 
both matrix metalloproteinases (MMPs) and recep-
tor activator for nuclear factor-kB (RANK) systems, 
which leads to the differentiation and activation of 
osteoclasts.9 In inflamed gingival tissues, IL-10 po-
tentiates local autoimmune responses characterized 
by increasing the number of anti-collagen secreting 
cells.10
Interestingly, transforming growth factor beta 
(TGF-β) is a highly conserved and ubiquitously ex-
pressed cytokine, and most cells express members 
of the TGF-β receptor family.11 During the progres-
sion of periodontal inflammation, periodontal liga-
ment and gingival fibroblasts secrete high levels of 
cytokines and chemokines.12 In one previous study, 
it was demonstrated that human gingival and peri-
odontal ligament fibroblasts distinctly responded to 
a time-course P. gingivalis LPS challenge with the 
production of macrophage inflammatory protein-
1α, stromal derived factor-1 and IL-6.13 The pres-
ent study further investigates the interrelationship 
between both subtypes of fibroblasts collected from 
the same donors in the production of TGF-β, IL-8 
and IL-10 when challenged with LPS.
Materials and Methods
Cell culture
Fibroblasts were obtained as previously de-
scribed.13 Briefly, human periodontal ligament fi-
broblasts were extracted from three healthy donors. 
Donors had given written informed consent, and the 
study was approved by the Ethics Committee of the 
Bauru School of Dentistry, University of São Paulo. 
Concurrently, gingival biopsies from the same do-
nors were obtained. Tissue fragments of periodon-
tal ligament and gingiva were individually plated in 
100 X 10 mm Petri dishes and covered with 5 mL of 
Dulbecco’s modified Eagle’s medium (DMEM; Invi-
trogen Life Technologies, Carlsbad, CA, USA) sup-
plemented with 10% fetal bovine serum (FBS; Cul-
tilab, Campinas, SP, Brazil) and antibiotics (600 µl/
mL penicillin, 300 µl/mL gentamicin sulfate, 100 µl/
mL amphotericin B; Invitrogen Life Technologies, 
Carlsbad, CA, USA). After minced, the explants were 
placed in 25-cm² flasks and incubated at 37°C in a 
humidified atmosphere of 5% CO2. Medium change 
(DMEM 10% FBS) was performed every second day. 
Cells were used at the fourth passage.
LPS challenge
Fibroblasts were seeded at a density of 5 x 104 
cells/well and incubated in the absence (controls) or 
presence of 0.1, 1 or 10 µg/mL of LPS from P. gingi-
valis (InvivoGen, San Diego, CA, USA) in duplicate 
as previously described.14 After 24  h, the superna-
tant was collected and analyzed by enzyme-linked 
immunosorbent assay (ELISA). 
ELISA
ELISAs, to determine the protein levels of 
TGF-β, IL-8 and IL-10, were performed using the 
Ready-Set-Go! ELISA kits (eBioscience, San Di-
ego, CA, USA), according to the manufacturer’s 
protocol. Dilutions were prepared in dilution buf-
fer. Briefly, 96-well plates were coated with anti-
human TGF-β, IL-8 or IL-10 monoclonal antibod-
ies. After blocking with the assay solution for 2 h 
to avoid non-specific binding, 100 µL of standard 
TGF-β, IL-8 or IL-10 or culture supernatants were 
added. The cytokines were detected by horseradish 
peroxidase-labeled monoclonal antibody to each 
target after 100 µL of anti-human biotinylated an-
tibodies were placed in each well and incubated for 
2 h at 21°C. The microplate was washed to remove 
unbound enzyme-labeled antibodies. The amount 
of horseradish peroxidase bound to each well was 
determined by the addition of substrate solution. 
The reaction was stopped by the addition of sulfuric 
acid and the plates were read at 450 nm (ELISA mi-
croplate reader, Bio-Rad, Hercules, CA, USA). The 
concentrations of each target were determined by 
interpolation from a standard curve and presented 
as pg/mL (± one standard error of the mean).
Statistical analysis
Statistical analysis was performed with Graph-
Pad Prism 5.0 software (GraphPad Prism 5.0, 
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cantly (p < 0.05) (Figure 2). Differences between the 
two subtypes of fibroblasts at any particular con-
centration were statistically undetectable regarding 
IL-8 production (Figure 2). 
IL-10 production is unaffected by LPS 
concentration in either fibroblast subtypes
In all concentrations of P. gingivalis LPS test-
ed (0  µg/mL to 10  µg/mL), periodontal ligament 
and gingival fibroblasts showed no changes in the 
amount of IL-10 when compared to control (Figure 
3). Additionally, there were no differences observed 
between them at each of the LPS concentrations 
tested in this study (Figure 3).
Discussion
This study investigated the in vitro responses 
of periodontal ligament and gingival fibroblasts 
provided by the same donors in response to a well-
known virulence factor from P. gingivalis, LPS, 
by quantifying important cytokines represented 
by TGF-β, IL-8 and IL-10. These cytokines along 
with others play a vital role in inflammatory disease 
such as periodontitis.15 An earlier work16 showed 
that the magnitude of the responses of gingival and 
periodontal ligament fibroblasts to P. gingivalis 
varies markedly between individuals. Particularly, 
it is possible that heterogeneity in the responses is 
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Figure 1 - TGF-β production by human cultured periodon-
tal ligament and gingival fibroblasts challenged with LPS 
from P. gingivalis. ELISA was performed for the quantification 
of the cytokines on the cell culture supernatants. #p < 0.05 
between the same cell subtype. *p < 0.05 between different 
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Figure 2 - IL-8 production by human cultured periodontal 
ligament and gingival fibroblasts challenged with LPS from 
P. gingivalis. ELISA was performed for the quantification of 
the cytokines on the cell culture supernatants. #p < 0.05 in 
comparison with the other concentrations of LPS in the same 
subtype.
GraphPad Software, San Diego, CA, USA). Data 
were compared using a one-way analysis of variance 
and differences were identified using the Tukey’s 
test, with significance set at p < 0.05. 
Results
TGF-β is distinctly produced by human 
gingival and periodontal ligament 
fibroblasts
When challenged with P.gingivalis LPS at a con-
centration of 10  µg/mL, gingival fibroblasts pro-
duced a significantly increased level of TGF-β when 
compared to control (Figure 1). As shown in Figure 
1, periodontal ligament fibroblasts treated with any 
concentration of LPS did not exhibit statistically 
significant differences when compared among any 
other LPS concentration or medium. At the highest 
LPS concentration tested, the TGF-β amounts de-
tected in gingival fibroblasts were almost two-fold 
(p  <  0.05) increased in comparison to the protein 
levels for periodontal ligament cells.
IL-8 levels in gingival and periodontal 
ligament fibroblasts were significant above 
1.0 µg/mL
There was no difference in IL-8 production at 
the lowest concentration of LPS tested (0.1 µg/mL) 
(Figure 2). However, when 1 µg/mL of P. gingivalis 
LPS was used, the amount of IL-8 increased signifi-
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and thus periodontal ligament fibroblasts and gin-
gival fibroblasts were collected and compared from 
the same donors.
Previously, other investigators have shown that 
viable P. gingivalis induces cytokine responses in 
monocytes and macrophages that are significantly 
different from those induced by purified LPS or by 
the major fimbrial protein FimA.17 For example, vi-
able P. gingivalis induced increased IL-6 and IL-8 
gene-expression when compared to dead P. gingiva-
lis in periodontal fibroblasts.16 The amount of TGF-β 
production was the only mediator that significantly 
differed between periodontal ligament and gingi-
val fibroblasts, and this difference was observed at 
the highest concentration of P. gingivalis LPS used. 
This result may indicate a more activated state for 
gingival fibroblasts over periodontal ligament cells, 
given that gingival fibroblasts are more likely to en-
counter oral pathogens. TGF- β is credited for pro-
moting wound fibroblasts to differentiation at sites 
of inflammation and repair.18 The unique pattern 
of production for cytokines by gingival fibroblasts 
observed could be due to its more pronounced re-
pair characteristic. In a previous study, we demon-
strated this distinct ability of cytokine production 
in these two subtypes of fibroblasts under the same 
challenge.13 Since these fibroblasts have different 
functional characteristics, it may be reasonable to 
assume that their role in the inflammatory process 
in periodontitis may also differ. An up-regulation 
in IL-6 levels was previously shown,13 which had a 
strong positive correlation with the levels of TGF-β 
reported in this work.
Taking this into account, studies have shown 
that the presence of IL-6, in addition to TGF- β, 
skews the commitment towards a population of 
CD4+ T helper cells discrete from Th1 and Th2, 
known as T helper type 17 cells (Th17).19,20 Th17 
cells are considered an independent T helper cell 
lineage in human and mouse which can potentially 
induce tissue inflammation and has been associated 
with the pathogenesis of many experimental auto-
immune diseases and human inflammatory condi-
tions. Moreover, it was found that TGF- β together 
with IL-6 induces massive amounts of IL-17 from 
naïve T cells and consequently these two cytokines 
together can differentiate Th 17 lineage. Interesting-
ly, two cytokines with opposing effects have to co-
operate to induce the differentiation of Th17 cells.21 
Also, the presence of Th17 cells in the chronic in-
flammation in human periodontal disease was dem-
onstrated as well as IL-17 expression in the alveolar 
bone of patients with chronic periodontitis.22 Stud-
ies linking apoptotic cell recognition and clearance 
report an induction of TGF- β secretion, resulting in 
accelerated resolution of inflammation.23 In an inde-
pendent study,18 TGF-β was found to be produced 
by LPS-treated human gingival fibroblasts and this 
level of TGF-β was unable to decrease IL-8 produc-
tion, corroborating our findings. 
In this study, 1 µg/mL of P. gingivalis LPS caused 
the levels of IL-8 production to increase significant-
ly (p < 0.05) for both gingival and periodontal liga-
ment fibroblasts. Even though the concentration of 
P. gingivalis LPS was 10 times greater, IL-8 release 
was maintained in both fibroblast subtypes. The 
fact that at least 1 µg/mL of P. gingivalis LPS caused 
IL-8 to significantly increase compared to control 
(p < 0.05) is curious. One could speculate that this 
may be at or close to the minimum concentration of 
LPS able to induce these cells to some pro-inflam-
matory reaction. It is still important to emphasize 
that IL-8 is an extensively studied chemokine relat-
ed to neutrophil recruitment,24 and it is essential in 
the first line of defense.













Control 0.1 µg/mL 1 µg/mL 10 µg/mL
PDLF
GF
Figure 3 - IL-10 production by human cultured periodontal 
ligament and gingival fibroblasts challenged with LPS from P. 
gingivalis. ELISA was performed for the quantification of the 
cytokines on the cell culture supernatant.
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control of periodontal disease progression.10 Con-
troversy still exists about IL-10’s expression pro-
file in periodontal health and disease. It has been 
shown that IL-10 levels in gingival crevicular fluid 
were only detected in samples from periodontal 
patients,25 and that T-cell lines derived from adult 
periodontitis subjects but not those from gingivitis 
subjects could produce IL-10.26 In contrast, IL-10 
expression in periodontitis lesions was less than that 
in healthy gingival tissue.27 In the current study, cu-
riously, no differences were found in IL-10 levels be-
tween fibroblasts with or without a P. gingivalis LPS 
challenge. In essence, this could be a consequence 
of an in vitro experimental model, which in some 
way might restrict the results, without considering 
the micro-environmental factors usually involved 
in vivo. Recent data has shown that in the early 
phases of inflammation, IL-10 expression was coor-
dinated with other genes expression that had potent 
pro-inflammatory and chemoattractant properties. 
Only during later stages, the function of IL-10 did 
converge into a congruent attempt to limit the tissue 
damage by dampening the inflammatory process.28 
This finding may indirectly explain the diversity of 
the IL-10 expression pattern observed in periodon-
tal health and disease. A recent study used gingival 
fibroblasts treated with P. gingivalis LPS for 48  h 
and reported increased expression of IL-10 when 
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